- Home
- SLQT vs DNTH Comparison
SLQT vs DNTH Comparison
Compare SLQT & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- DNTH
- Stock Information
- Founded
- SLQT 1999
- DNTH 2015
- Country
- SLQT United States
- DNTH United States
- Employees
- SLQT N/A
- DNTH N/A
- Industry
- SLQT Specialty Insurers
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- DNTH Health Care
- Exchange
- SLQT Nasdaq
- DNTH Nasdaq
- Market Cap
- SLQT 566.4M
- DNTH 568.6M
- IPO Year
- SLQT 2020
- DNTH N/A
- Fundamental
- Price
- SLQT $2.23
- DNTH $16.86
- Analyst Decision
- SLQT Hold
- DNTH Strong Buy
- Analyst Count
- SLQT 2
- DNTH 8
- Target Price
- SLQT $3.38
- DNTH $53.00
- AVG Volume (30 Days)
- SLQT 887.2K
- DNTH 277.7K
- Earning Date
- SLQT 05-12-2025
- DNTH 08-07-2025
- Dividend Yield
- SLQT N/A
- DNTH N/A
- EPS Growth
- SLQT N/A
- DNTH N/A
- EPS
- SLQT N/A
- DNTH N/A
- Revenue
- SLQT $1,488,701,000.00
- DNTH $6,524,000.00
- Revenue This Year
- SLQT $17.72
- DNTH N/A
- Revenue Next Year
- SLQT $13.05
- DNTH N/A
- P/E Ratio
- SLQT N/A
- DNTH N/A
- Revenue Growth
- SLQT 20.41
- DNTH 102.36
- 52 Week Low
- SLQT $1.62
- DNTH $13.37
- 52 Week High
- SLQT $6.86
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- SLQT 44.26
- DNTH 38.63
- Support Level
- SLQT $2.18
- DNTH $17.67
- Resistance Level
- SLQT $2.31
- DNTH $19.58
- Average True Range (ATR)
- SLQT 0.09
- DNTH 1.14
- MACD
- SLQT 0.04
- DNTH -0.07
- Stochastic Oscillator
- SLQT 51.02
- DNTH 3.20
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.